Hepatocellular uptake of sulfobromophthalein and bilirubin is selectively inhibited by an antibody to the liver plasma membrane sulfobromophthalein/bilirubin binding protein

The Journal of Clinical Investigation
W Stremmel, P D Berk

Abstract

To clarify sulfobromophthalein (BSP) and bilirubin uptake mechanisms, isolated rat hepatocytes were incubated with [35S]BSP. The initial uptake velocity (V0), determined from the first, linear portion of the cumulative uptake curve, was saturable (Michaelis constant [Km] = 6.2 +/- 0.5 microM; Vmax = 638 +/- 33 pmol X min-1 per 10(5) hepatocytes), maximal at 37 degrees C and pH 7.4, and competitively inhibited by bilirubin, but not by taurocholate, cholate, or oleate. Preloading with unlabeled BSP led to trans-stimulation of V0. Sodium substitution or pretreatment of hepatocytes with ouabain or metabolic inhibitors had no effect on V0; trypsin reduced V0 by 39% (P less than 0.001). A rabbit antiserum to the rat liver plasma membrane (LPM)-BSP/bilirubin binding protein selectively reduced V0 of 5 microM [35S]BSP and [14C]bilirubin by 41 and 42%, respectively (P less than 0.01); uptakes of [3H]oleate, [3H]cholate and [3H]taurocholate were not affected. Hence, the LPM-BSP/bilirubin binding protein plays a role in the carrier-mediated uptake of BSP and bilirubin by hepatocytes.

References

Feb 1, 1976·The Journal of Clinical Investigation·L Accatino, F R Simon
Nov 28, 1979·Biochemical and Biophysical Research Communications·J Reichen, P D Berk
Jan 25, 1978·Biochimica Et Biophysica Acta·C TiribelliG Sottocasa
Nov 1, 1975·The Journal of Clinical Investigation·B F ScharschmidtP D Berk
Jun 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·W StremmelP D Berk
Mar 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·R A Weisiger
Jan 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·W StremmelP D Berk
Aug 1, 1985·The Journal of Clinical Investigation·A W WolkoffR J Stockert
Feb 1, 1966·The Journal of Clinical Investigation·K J Baker, S E Bradley
Nov 1, 1983·The Journal of Clinical Investigation·E L Forker, B A Luxon
Apr 15, 1983·Biochemical and Biophysical Research Communications·W StremmelP D Berk
Feb 23, 1982·Biochimica Et Biophysica Acta·G L SottocasaC Tiribelli
Feb 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·B F Scharschmidt, J E Stephens
May 1, 1981·The Journal of Clinical Investigation·E L Forker, B A Luxon

❮ Previous
Next ❯

Citations

Jul 10, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·C M NoyerA W Wolkoff
Jan 1, 1991·Toxicon : Official Journal of the International Society on Toxinology·M T RunnegarI R Falconer
Jan 1, 1987·Molecular Aspects of Medicine·D SorrentinoP D Berk
Oct 8, 1990·Biochimica Et Biophysica Acta·C TiribelliG L Sottocasa
Jul 17, 1995·Biochimica Et Biophysica Acta·R P Oude ElferinkG M Groothuis
Oct 1, 1995·Toxicology in Vitro : an International Journal Published in Association with BIBRA·P F WrightN H Stacey
Jan 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·W SchwietermanP D Berk
Sep 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·A M TorresC Tiribelli
Nov 1, 1996·Journal of Gastroenterology and Hepatology·A M Torres
Aug 7, 2002·Clinical Pharmacokinetics·Michael S RobertsMichael Weiss
Dec 1, 2012·World Journal of Gastroenterology : WJG·Anabel BrandoniAdriana Mónica Torres
Dec 25, 2004·Drug Metabolism and Pharmacokinetics·Syunsuke ShimadaJunji Kojima
Oct 1, 1994·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·B J PotterP D Berk
Dec 1, 1994·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·S A Weinman
Feb 1, 1990·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·C Tiribelli, J D Ostrow
Oct 1, 1995·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·W P GengK S Pang
Jan 1, 1987·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·P D BerkW Stremmel
Oct 31, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Paul D Berk
Jun 11, 1999·The American Journal of Physiology·F Wehner, H Tinel
Jul 17, 1999·The American Journal of Physiology·M LundP Ott
Apr 14, 2004·Liver International : Official Journal of the International Association for the Study of the Liver·Deha ErdoganThomas M van Gulik
Jun 1, 1991·Gastroenterologia Japonica·Y AdachiI M Arias
Feb 17, 2000·Biochimica Et Biophysica Acta·S D Zucker, W Goessling
Apr 9, 1987·Biochimica Et Biophysica Acta·B J PotterP D Berk
Mar 1, 1992·Journal of Hepatology·C Tiribelli

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.